Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

12.25
Delayed Data
As of Apr 29
 -0.64 / -4.97%
Today’s Change
9.89
Today|||52-Week Range
24.82
-16.21%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close12.89
Today’s open12.81
Day’s range12.04 - 12.87
Volume171,331
Average volume (3 months)290,387
Market cap$525.2M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+13.46%
Earnings growth (this year)-133.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+191.62%
P/E ratioNM
Price/Sales20.55
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.16-1.19%
RVNCRevance Therapeutics...-0.41-2.18%
TGTXTG Therapeutics Inc-0.31-3.29%
CLVSClovis Oncology Inc-0.57-3.94%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$27.8M
Annual profit (last year)-$17.6M
Net profit margin-63.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts

Partner Offers

Search for Jobs